ALZ-101 Clinical Trials (2026): 1 Studies for Alzheimer Disease & Dementia Alzheimers
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ALZ-101 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Alzheimer Disease & Dementia Alzheimers) and 33 total planned enrollment. Most recent activity: NCT05328115 (Jan 2025).
ALZ-101 clinical trials at a glance: phase × recruitment status
| Phase | completed | Total |
|---|---|---|
| P1 | 1 | 1 |
All ALZ-101 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT05328115 | A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease | P1 | completed | 33 | Alzinova AB | Sep 2021 |
ALZ-101 clinical trials: frequently asked questions
- How many ALZ-101 clinical trials are there?
- 1 ALZ-101 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is marked completed.
- Are ALZ-101 clinical trials recruiting in 2026?
- No active ALZ-101 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is ALZ-101 being studied for?
- ALZ-101 is being studied for Alzheimer Disease, Dementia Alzheimers, Dementia, Mild. The trials are grouped by indication on this page.
- What phase is ALZ-101 in?
- ALZ-101 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ALZ-101 clinical trials?
- The lead sponsor across the most ALZ-101 trials is Alzinova AB. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ALZ-101as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: